Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Structure (London, England : 1993)|August 20, 2013
Structural rearrangement in an RsmA/CsrA ortholog of Pseudomonas aeruginosa creates a dimeric RNA-binding protein, RsmNElizabeth R Morris, Gareth Hall, Chan Li, et al.
Plos One|July 17, 2023
Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic toolKovilen Sawmynaden, Nicholas Wong, Sarah Davies, et al.
Molecular Psychiatry|November 15, 2021
Discovery of a novel pseudo β-hairpin structure of N-truncated amyloid-β for use as a vaccine against Alzheimer's diseasePreeti Bakrania, Gareth Hall, Yvonne Bouter, et al.
The Journal of Biological Chemistry|May 28, 2016
Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16): MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIESGareth Hall, Eilish Cullen, Kovilen Sawmynaden, et al.
The Journal of Biological Chemistry|December 5, 2022
Identification, binding, and structural characterization of single domain anti-PD-L1 antibodies inhibitory of immune regulatory proteins PD-1 and CD80Tara Kang-Pettinger, Kayleigh Walker, Richard Brown, et al.
Frontiers in Immunology|July 24, 2023
Identification and characterisation of anti-IL-13 inhibitory single domain antibodies provides new insights into receptor selectivity and attractive opportunities for drug discoveryKayleigh Walker, Roberta Baravalle, Rachel Holyfield, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2020
Allosteric activation of MALT1 by its ubiquitin-binding Ig3 domainRebekka Schairer, Gareth Hall, Ming Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2023
Evaluating the druggability of TrmD, a potential antibacterial target, through design and microbiological profiling of a series of potent TrmD inhibitorsAndrew J Wilkinson, Nicola Ooi, Jonathan Finlayson, et al.
Frontiers in Immunology|July 2, 2021
Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient ResponsesGeorgia Bullen, Jacob D Galson, Gareth Hall, et al.
Pageof 2